|
|
| | | What you need to know about the coronavirus today |
| |
Merkel lashes out at populists Populists who argue the coronavirus is harmless are dangerous and irresponsible, German Chancellor Angela Merkel said on Thursday, defending a circuit-break lockdown aimed at slowing the spread of the virus. "We are in a dramatic situation at the start of the cold season. It affects us all, without exception," Merkel told the Bundestag lower house of parliament, adding new restrictions to reduce social contact were "necessary and proportionate". She said populists who question the seriousness of the crisis were putting lives at risk.
Poland's total cases top 300,000 Poland reported another daily record of coronavirus infections and deaths on Thursday with 20,156 new cases and 301 deaths related to COVID-19. The health ministry said the total number of confirmed coronavirus infections had tripled in less than a month, exceeding 300,000. Government officials have warned infections could rise fast due to massive protests sweeping Poland following a Constitutional Court ruling last Thursday that has introduced a near total ban on abortions.
Hospitals in Wisconsin, Texas under strain UW Health University Hospital in Madison, Wisconsin, has been rushing to convert available space into units for COVID-19 patients, as the state's medical facilities struggle to keep pace with new infections. As part of the effort, the medical center opened a new intensive care unit this week ahead of schedule, and it is quickly filling with coronavirus patients. "Today we have more patients than we've had ever before," said Dr. Jeff Pothof, an emergency medicine physician at UW Health. "It's putting a strain on our capacity. Our biggest concern is ICU staffing."
Breathalyser gives results in seconds A company in Singapore has developed a breathalyser test for the new coronavirus which it says will enable people to know whether they are infected in under a minute. Breathonix, a startup firm from the National University of Singapore, says its test achieved more than 90% accuracy in a pilot clinical trial of 180 people in the city state and hopes to get regulatory approval early next year. Countries worldwide are looking to develop alternative tests to the Polymerase Chain Reaction nasal swab, which is invasive and in short supply in some places where demand has outstripped manufacturers' production capacity. | |
| |
From Breakingviews - Corona Capital: Vaccines, Shell, China/cars, KFC Demand for winter flu jabs boosts French drugmaker Sanofi, while Royal Dutch Shell has given bruised shareholders another dividend surprise. Catch up with the latest financial insights. | |
| |
Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | |
|
| |
|
|
|
|
| | Top Stories on Reuters TV |
|
| |
|
|
|